Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use
| Autor: | Andrea S, Melani, PierAldo, Canessa, Isotta, Coloretti, Giuseppe, DeAngelis, Renato, DeTullio, Mario, Del Donno, Raffaela, Giacobbe, Ines, Scarlato, Antonella, Serafini, Natalino, Barbato, Adriano, Vaghi, Piersante, Sestini, Doriana, Zanchetta |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine medicine.medical_specialty Cross-sectional study Self Administration Drug Administration Schedule Medication Adherence Pulmonary Disease Chronic Obstructive Young Adult Patient Education as Topic Administration Inhalation medicine Inhaler technique Humans COPD Young adult Glucocorticoids Aged Asthma Nebuliser Aerosol therapy Inhalation business.industry Nebulizers and Vaporizers Inhaler Age Factors Patient education Middle Aged medicine.disease Bronchodilator Agents Cross-Sectional Studies Italy Emergency medicine Physical therapy Female Observational study business |
| Zdroj: | Respiratory Medicine. 106(5):668-676 |
| ISSN: | 0954-6111 |
| DOI: | 10.1016/j.rmed.2011.11.016 |
| Popis: | Summary Inhalers and nebulisers are devices used for delivering aerosolised drugs in subjects with Chronic Airflow Obstruction (CAO). This multicentre, cross-sectional observational study was performed in a large population of outpatients with CAO regularly using home aerosol therapy and referring to chest clinics. The aims of the study were to compare the characteristics of the group of subjects with CAO who were using home nebulisers but also experienced with inhalers vs. those only using inhalers and to investigate whether the first group of subjects was particularly prone to inhaler misuse. Information was gained evaluating the responses to a standardised questionnaire on home aerosol therapy and the observations of inhaler technique. We enrolled 1527 patients (58% males; mean ± SE; aged 61.1 ± 0.4 years; FEV1% pred 69.9 ± 0.6; 51% and 44% respectively suffering from COPD and asthma) who were only inhaler users (OIU group) and 137 (85% males; aged 67.7 ± 1.3 years; FEV1% pred 62.3 ± 2.9; 60% and 23% respectively suffering from COPD and asthma) who were using both nebulisers and inhalers (NIU group). Nebuliser users were older, had more severe obstruction, related symptoms and health care resources utilisation. Nebulisers users performed more critical inhalers errors than those of the OIU group (49% vs. 36%; p = 0.009). We conclude that our patients with CAO and regular nebuliser treatment had advanced age, severe respiratory conditions and common inhaler misuse. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect